Circulating apoptotic markers in the management of non-small cell lung cancer.

Abstract

The dysregulation of proliferating and apoptotic processes is a common feature in cancerogenesis. Thus, apoptotic products released into blood circulation are suggested as promising markers for the early cancer detection. However though sensitive assays are available, the lack of organ- and tumor-specificity limits the usefulness of most apoptotic… (More)
DOI: 10.3233/CBM-2009-0130

Topics

1 Figure or Table

Cite this paper

@article{Holdenrieder2010CirculatingAM, title={Circulating apoptotic markers in the management of non-small cell lung cancer.}, author={Stefan Holdenrieder and Petra Stieber}, journal={Cancer biomarkers : section A of Disease markers}, year={2010}, volume={6 3-4}, pages={197-210} }